Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Interview with Dallas Webb, portfolio manager BB Biotech about what the future holds for biotechnology, how Covid-19 has played a role in accelerating adoption of emerging therapies, and what some of the most exciting developments are in the sector. Read the whole interview on Investment Week.

«The fundamentals of biotech have never been stronger»

Interview with Dallas Webb, portfolio manager BB Biotech about what the future holds for biotechnology, how Covid-19 has played a role in accelerating adoption of emerging therapies, and what some of the most exciting developments are in the sector. Read the whole interview on Investment Week.
25.01.2022 - Dallas Webb

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 23.47%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993